Hans Edgar Bishop - 05 Jul 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director
Signature
/s/ Julie Shah, Attorney-in-Fact for Hans Edgar Bishop
Issuer symbol
SANA
Transactions as of
05 Jul 2023
Net transactions value
$0
Form type
4
Filing time
06 Jul 2023, 16:21:24 UTC
Previous filing
20 Jun 2023
Next filing
08 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Award $0 +4,152 +0.07% $0.000000 5,765,040 05 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested restricted stock units for which the Reporting Person has elected to defer settlement until January 1, 2024 pursuant to Sana Biotechnology, Inc.'s Non-Employee Director Compensation Program.